Prognostic variables in recurrent limb melanoma treated with hyperthermic antiblastic perfusion

F. Di Filippo, A. Calabro, D. Giannarelli, S. Carlini, F. Cavaliere, F. Moscarelli, R. Cavaliere

Research output: Contribution to journalArticle

112 Citations (Scopus)

Abstract

Between October 1969 and December 1986, 136 patients with recurrent limb melanoma were treated with hyperthermic antiblastic perfusion (HAP). This retrospective analysis is aimed at identifying tumor-related and treatment-related variables likely to influence tumor response, locoregional control, disease-free survival, and overall survival. Independent factors predicting a complete response (CR) were the number of lesions (P

Original languageEnglish
Pages (from-to)2551-2561
Number of pages11
JournalCancer
Volume63
Issue number12
Publication statusPublished - 1989

Fingerprint

Melanoma
Extremities
Perfusion
Disease-Free Survival
Neoplasms
Survival
Therapeutics

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Di Filippo, F., Calabro, A., Giannarelli, D., Carlini, S., Cavaliere, F., Moscarelli, F., & Cavaliere, R. (1989). Prognostic variables in recurrent limb melanoma treated with hyperthermic antiblastic perfusion. Cancer, 63(12), 2551-2561.

Prognostic variables in recurrent limb melanoma treated with hyperthermic antiblastic perfusion. / Di Filippo, F.; Calabro, A.; Giannarelli, D.; Carlini, S.; Cavaliere, F.; Moscarelli, F.; Cavaliere, R.

In: Cancer, Vol. 63, No. 12, 1989, p. 2551-2561.

Research output: Contribution to journalArticle

Di Filippo, F, Calabro, A, Giannarelli, D, Carlini, S, Cavaliere, F, Moscarelli, F & Cavaliere, R 1989, 'Prognostic variables in recurrent limb melanoma treated with hyperthermic antiblastic perfusion', Cancer, vol. 63, no. 12, pp. 2551-2561.
Di Filippo F, Calabro A, Giannarelli D, Carlini S, Cavaliere F, Moscarelli F et al. Prognostic variables in recurrent limb melanoma treated with hyperthermic antiblastic perfusion. Cancer. 1989;63(12):2551-2561.
Di Filippo, F. ; Calabro, A. ; Giannarelli, D. ; Carlini, S. ; Cavaliere, F. ; Moscarelli, F. ; Cavaliere, R. / Prognostic variables in recurrent limb melanoma treated with hyperthermic antiblastic perfusion. In: Cancer. 1989 ; Vol. 63, No. 12. pp. 2551-2561.
@article{49ae87e7804a4e9893b8a9188c195776,
title = "Prognostic variables in recurrent limb melanoma treated with hyperthermic antiblastic perfusion",
abstract = "Between October 1969 and December 1986, 136 patients with recurrent limb melanoma were treated with hyperthermic antiblastic perfusion (HAP). This retrospective analysis is aimed at identifying tumor-related and treatment-related variables likely to influence tumor response, locoregional control, disease-free survival, and overall survival. Independent factors predicting a complete response (CR) were the number of lesions (P",
author = "{Di Filippo}, F. and A. Calabro and D. Giannarelli and S. Carlini and F. Cavaliere and F. Moscarelli and R. Cavaliere",
year = "1989",
language = "English",
volume = "63",
pages = "2551--2561",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "12",

}

TY - JOUR

T1 - Prognostic variables in recurrent limb melanoma treated with hyperthermic antiblastic perfusion

AU - Di Filippo, F.

AU - Calabro, A.

AU - Giannarelli, D.

AU - Carlini, S.

AU - Cavaliere, F.

AU - Moscarelli, F.

AU - Cavaliere, R.

PY - 1989

Y1 - 1989

N2 - Between October 1969 and December 1986, 136 patients with recurrent limb melanoma were treated with hyperthermic antiblastic perfusion (HAP). This retrospective analysis is aimed at identifying tumor-related and treatment-related variables likely to influence tumor response, locoregional control, disease-free survival, and overall survival. Independent factors predicting a complete response (CR) were the number of lesions (P

AB - Between October 1969 and December 1986, 136 patients with recurrent limb melanoma were treated with hyperthermic antiblastic perfusion (HAP). This retrospective analysis is aimed at identifying tumor-related and treatment-related variables likely to influence tumor response, locoregional control, disease-free survival, and overall survival. Independent factors predicting a complete response (CR) were the number of lesions (P

UR - http://www.scopus.com/inward/record.url?scp=0024375953&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024375953&partnerID=8YFLogxK

M3 - Article

C2 - 2720604

AN - SCOPUS:0024375953

VL - 63

SP - 2551

EP - 2561

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 12

ER -